Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $53.53B.
ENTERPRISE VALUE (EV)
$53.53B
Moderna, Inc.
Market Cap
$54.88B
Enterprise Value (EV)
$53.53B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Moderna, Inc. (MRNA) | $54.88B | $53.53B |
| Cardinal Health, Inc. (CAH)vs › | $56.42B | $61.42B |
| Edwards Lifesciences Corporation (EW)vs › | $49.80B | $47.73B |
| Becton, Dickinson and Company (BDX)vs › | $49.65B | $65.45B |
| Humana Inc. (HUM)vs › | $47.74B | $55.76B |
| Cencora, Inc. (COR)vs › | $63.43B | $72.08B |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.89B | $56.03B |
| IQVIA Holdings Inc. (IQV)vs › | $42.23B | $57.00B |
| Boston Scientific Corporation (BSX)vs › | $67.98B | $78.94B |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.92B | $41.93B |
Market Cap
$54.88B
Total Debt
$1.24B
Cash
$2.60B
Enterprise Value
$53.53B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
